GENZYME H-1B Visa Sponsorship & Salary Data

The median H-1B salary at GENZYME is $119,995, based on 139 certified filings from FY 2020 to FY 2026. This is equal to the national H-1B median salary of $120,000. Compensation at GENZYME reflects their market positioning, with entry-level roles starting around $105,000 and senior positions reaching $189,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at GENZYME range from $85,000 at the 10th percentile to $189,000 at the 90th percentile, showing a $104,000 spread across experience levels and roles. The 25th percentile is $105,000 and the 75th percentile is $147,712.

Yes, GENZYME actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 142 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 139 certified applications and a 0% denial rate, GENZYME maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), GENZYME filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, GENZYME has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

GENZYME's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 142 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating GENZYME as a potential H-1B sponsor.

This is an excellent approval rate, indicating GENZYME has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

GENZYME sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 139 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles GENZYME most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at GENZYME:

The most frequently sponsored role is Research Scientist with 8 filings at a median salary of $105,331. This is followed by Senior Research Scientist (5 filings) and Systems Support Manager.

GENZYME's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where GENZYME sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top GENZYME H-1B locations:

The largest H-1B hub for GENZYME is Cambridge, MA with 89 filings at a median salary of $125,250. The highest-paying location is Detroit, MI at $183,750 median. Salaries range from $76,000 to $183,750 across office locations.

GENZYME's median H-1B salary has increased by +20% from FY 2020 ($122,211) to FY 2026 ($147,000). Tracking salary trends over time reveals how GENZYME adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at GENZYME.

Year-by-year breakdown:

• FY 2022: $115,500 (25 certified)
• FY 2023: $139,464 (25 certified)
• FY 2024: $120,000 (22 certified)
• FY 2025: $140,625 (23 certified)
• FY 2026: $147,000 (2 certified)

GENZYME has maintained steady salary growth for H-1B positions over this period.

GENZYME primarily files H-1B applications at Wage Level IV, accounting for 43% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making GENZYME's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 93% of positions at Level II or higher, GENZYME typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

GENZYME's median H-1B salary of $119,995 is equal to the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating GENZYME's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare GENZYME's offerings with similar companies in your field for a more accurate assessment.

GENZYME's H-1B salaries are competitive with industry averages. The 139 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. GENZYME's higher proportion of Level III-IV positions (65%) may benefit from wage-based lottery prioritization.

With 139 certified filings, GENZYME invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.